George Weston Limited Announces Three-for-One Stock Split Français
Weston is undertaking the stock split to ensure its Common Shares remain accessible to retail investors and employees who participate in the Company's Employee Share Ownership Plan, and to improve the liquidity of the Common Shares. The stock split will not dilute shareholders' equity. As the aggregate declared amount of the stock dividend on the Common Shares is nominal, there will be no Canadian income tax payable by shareholders related to this transaction. For more information, shareholders should consult with their own tax advisor.
The Common Shares will begin trading ex-dividend (post-split) on the Toronto Stock Exchange at the opening of business on August 19, 2025. Common shares will trade on a "due bill" basis from the opening of business on August 14, 2025 until the close of business on August 18, 2025, inclusively, where shares will carry the right to receive the additional shares to be issued in connection with the stock dividend.
About George Weston Limited
George Weston Limited is a Canadian public company founded in 1882. The Company operates through its two reportable operating segments, Loblaw Companies Limited and Choice Properties Real Estate Investment Trust. Loblaw provides Canadians with grocery, pharmacy, health and beauty, apparel, general merchandise, financial services and wireless mobile products and services. Choice Properties owns, manages and develops a high-quality portfolio of commercial and residential properties across Canada.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
a few seconds ago
- Globe and Mail
Levi & Korsinsky Notifies 3D Systems Corporation (DDD) Shareholders of Class Action Lawsuit and August 12, 2025 Deadline
New York, New York--(Newsfile Corp. - August 4, 2025) - If you suffered a loss on your 3D Systems Corporation (NYSE: DDD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against 3D Systems Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (ii) in addition, the updated milestone criteria in the partnership with United Therapeutics Corporation would negatively impact the Company's regenerative medicine program revenue; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times. WHAT'S NEXT? If you suffered a loss in 3D Systems Corporation stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CTV News
a few seconds ago
- CTV News
Two of Canada's most senior ministers head to Mexico to talk discuss trade
The flags of Mexico and Canada fly near the Ambassador Bridge, Monday, Feb. 3, 2025, in Detroit. (AP Photo/Paul Sancya) Two of Canada's most senior cabinet ministers will be in Mexico City this week holding bilateral meetings with government officials and the Mexican president, as Canada looks to improve its trading partnerships outside the United States. Senior government officials confirmed to CTV News that the meeting, which will involve Finance Minister Francois-Philippe Champagne and Foreign Affairs Minister Anita Anand, will take place Tuesday and Wednesday. The talks are expected to cover trade and the larger relationship between the two countries. That relationship suffered in the past year, when Ontario Premier Doug Ford called on Canada to seek a unilateral trade deal with the United States – without Mexico – and accused the country of undercutting North American manufacturers. Canadian business leaders say the upcoming talks show an effort to strengthen ties at a time when both countries are facing volatility from the United States. 'When we talk to Mexico, when we talk to their embassies in Canada, they are very eager to reset the relationship,' Catherine Fortin-LeFaivre, senior vice-president of International Policy and Global Partnerships at the Canadian Chamber of Commerce, said Sunday. While Canada faces new blanket 35 per cent tariffs on Canadian goods that aren't covered under the Canada-United States-Mexico Agreement, Mexico received a 90-day extension to continue trade talks with the U.S. before it sees blanket tariffs increase from 25 per cent to 35 per cent. Last month, Prime Minister Mark Carney and Mexican President Claudia Sheinbaum spoke over the phone, with the two leaders agreeing to improve trade collaboration between the two nations. Carlo Dade, director of international policy at the University of Calgary's School of Public Police, said Canada having open dialogue and strong ties with Mexico is 'a good sign.' 'If we weren't talking to Mexico, there would be reason to be concerned and worried,' Dade told CTV News. He added that Canada hasn't taken advantage of being in close proximity to a country like Mexico that has a higher per-capita GDP than China. 'The infrastructure is there, we have CPKC - Canada-Pacific Kansas City Railroad - so there's (an) integrated North American railroad,' Dade said. 'We have a trade agreement, we have decades of strong, strong, political and economic relations – the only missing factor has been a willingness of Canadian business to seize the opportunities. Mexico has been marked as a priority market to expand trade with by Export Development Canada. While it is already Canada's third-largest trading partner, with nearly $56 billion dollars in two-way merchandise crossing the border in 2024, it represented just over one per cent of Canadian exports that year. Fortin-LeFaivre says those relations will be crucial, particularly if the United States looks to move from a trilateral free trade agreement to two bilateral deals. 'It will be imperative that if that is happening that we have a very strong connection with Mexico directly, without the U.S. being there,' she said. Friday, Carney reiterated Canada's commitment to the CUSMA agreement while condemning Trump's recent tariff increase.
Cision Canada
30 minutes ago
- Cision Canada
LSL PHARMA GROUP ANNOUNCES THE COMPLETION OF EARLY REDEMPTION OF ALL 11% UNSECURED CONVERTIBLE DEBENTURES
BOUCHERVILLE, QC, Aug. 4, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (" LSL Pharma" or the " Corporation"), a Canadian integrated pharmaceutical company, today announced that it has completed the early redemption and cancellation of all issued and outstanding 11.0% Unsecured Convertible Debentures (originally scheduled to mature on October 31, 2028) (the " Debentures"). Pursuant to the Company's announcement on July 2, 2025, Debenture holders were paid an aggregate amount of $3,505,098.08, representing (i) $3,288,000 as the principal amount of the Debentures, (ii) the early repayment premium pursuant to the trust indenture dated November 1, 2023 between the Corporation and the Trustee ,TSX Trust Company and (iii) all accrued and unpaid interest up to but excluding the Redemption Date. As a result of the early redemption, all Debentures, previously listed on the TSX Venture Exchange (" TSXV") under the symbol were delisted and have ceased trading on August 1, 2025, in accordance with TSXV policies. ABOUT LSL PHARMA GROUP INC. LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. Companies forming part of LSL Pharma Group include Steri-Med Pharma Inc., LSL Laboratory Inc., Virage Santé Inc. and Dermolab Pharma Ltd. For further information, please visit our website at CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements as defined under applicable Canadian securities legislation. Forward-looking statements can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "continue" or similar expressions. Forward-looking statements are based on a number of assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Corporation's ability to control or predict, that could cause actual results or performance to differ materially from those expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, those identified in the Corporation's filings with Canadian securities regulatory authorities, such as legislative or regulatory developments, increased competition, technological change and general economic conditions. All forward-looking statements made herein should be read in conjunction with such documents. Readers are cautioned not to place undue reliance on forward-looking statements. No assurance can be given that any of the events referred to in the forward-looking statements will transpire, and if any of them do, the actual results, performance or achievements of the Corporation may differ materially from those expressed or implied by the forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. The Corporation does not undertake to update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) have reviewed or accept responsibility for the adequacy or accuracy of this release. SOURCE Groupe LSL PHARMA INC.
